Pfizer files patent infringement petition in US court against Aurobindo, Dr Reddy’s
Alleges that these Indian pharma companies were planning separately to come out with generic versions of its cancer drug Ibrance…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Aurobindo Pharma
Aurobindo Pharma to divest Natrol to New Mountain Capital
Aurobindo Pharma has reached a definitive agreement to sell Natrol, a wholly owned subsidiary of Aurobindo Pharma US, to an…
Aurobindo Pharma receives USFDA approval for Acetaminophen Injection
it is indicated for the treatment of mild to moderate pain in adult and paediatric patients two years and older.
Aurobindo Pharma acquires 100 per cent share of Eugia Pharma Specialities
The cost of acquisition is Rs 274.22 crores for a total of 15,02,49,382 equity shares
CSIR and Aurobindo Pharma to collaborate for COVID-19 vaccine development
DBT is also supporting Aurobindo Pharma’s COVID-19 vaccine development through its wholly-owned US subsidiary Auro Vaccines, under…
Merck files petition in US court against Aurobindo Pharma for Janumet
In June, Merck had filed a petition against Dr Reddy's Laboratories in a US court over similar patent issues on Janumet and…
Aurobindo Pharma expects Phase I and II trials of COVID-19 vaccine by end of 2020
The company's viral vaccine manufacturing capacity in India would be undertaken in two phases, the first phase would be ready by…
Aurobindo Pharma joins COVID-19 vaccine hunt
The company’s vaccine candidate has been shortlisted for BIRAC funding, will launch final product by the end of 2022
Pharmexcil asks industry for details of levied demurrage charges
Reportedly, demurrage charges of approximately Rs 3 crores have been imposed on the pharma sector
Indian pharma firms recall medications from US market
Lupin and Marksans Pharma recall diabetes drugs while Alembic and Aurbindo recall medicines that treat mental disorders